Evelien Roekevisch
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Can serum biomarkers predict the outcome of systemic immunosuppressive therapy in adult atopic dermatitis patients?
Journal: Skin health and disease
Published: September 22, 2021
Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patients.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: April 25, 2019
Relationship and probabilistic stratification of Eczema Area and Severity Index and objective Scoring Atopic Dermatitis severity scores for atopic dermatitis.
Journal: The British journal of dermatology
Published: June 27, 2018
Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial.
Journal: The British journal of dermatology
Published: December 06, 2017
Methotrexate versus azathioprine in patients with atopic dermatitis: 2-year follow-up data.
Journal: The Journal of allergy and clinical immunology
Published: March 15, 2017
Patients with atopic dermatitis with filaggrin loss-of-function mutations show good but lower responses to immunosuppressive treatment.
Journal: The British journal of dermatology
Published: November 20, 2016
Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 04, 2014
Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
Journal: The Journal of allergy and clinical immunology
Published: March 25, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026